-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

Benzinga·07/09/2025 11:12:56
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $5 price target.